Sanofi Pasteur has begun shipment of its influenza vaccine in the U.S. for the 2007-2008 season.
Sanofi Pasteur has begun shipment of its influenza vaccine in the U.S. for the 2007-2008 season. The first batches will go to CDC for distribution within its Vaccines for Children program. They will be followed by partial shipments to customers as part of their split-delivery process that will continue until the end of October, when all orders should be complete. According to the company, it produces approximately half of the flu vaccine used worldwide and 40% of the U.S. total. The new season's formulation contains an A/Solomon Islands/3/2006 (H1N1)-like virus, an A/Wisconsin/67/2005 (H3N2)-like virus, and a B/Malaysia/2506/2004-like virus. The three strains were approved by the FDA in February 2007.